Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

RAD51 Antikörper (AA 1-134)

Der Maus Monoklonal Anti-RAD51-Antikörper wurde für FACS und IHC (f) validiert. Er ist geeignet, RAD51 in Proben von Human zu detektieren.
Produktnummer ABIN6938307

Kurzübersicht für RAD51 Antikörper (AA 1-134) (ABIN6938307)

Target

Alle RAD51 Antikörper anzeigen
RAD51 (DNA Repair Protein Homolog 1 (RAD51))

Reaktivität

  • 165
  • 76
  • 38
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 107
  • 61
  • 1
Maus

Klonalität

  • 98
  • 71
Monoklonal

Konjugat

  • 82
  • 9
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Dieser RAD51 Antikörper ist unkonjugiert

Applikation

  • 117
  • 40
  • 40
  • 38
  • 29
  • 29
  • 22
  • 21
  • 11
  • 11
  • 10
  • 9
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

RAD51-2702
  • Bindungsspezifität

    • 47
    • 23
    • 15
    • 11
    • 7
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-134

    Spezifität

    RAD51 is one of the key factors of DNA repair by homologous recombination and has been shown to have anti-apoptotic activity in tumor cells. RAD51 protein interacts with a variety of tumor suppressor proteins including p53, BRCA1 and BRCA2. Elevated expression of RAD51 enhances radio-resistance of human tumor cells. Overexpression of RAD51 protein in tumor cells renders them resistant against cytotoxic drugs like Cisplatin. RAD51 interacts with BRCA1 and BRCA2 to influence subcellular localization and cellular response to DNA damage. BRCA2 inactivation may be a key event leading to genomic instability and tumorigenesis from deregulation of RAD51. High-level expression of RAD51 has been observed in a variety of human malignancies.RAD51 overexpression correlates with histological grading of the tumor in invasive ductal mammary carcinoma.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment of human RAD51 protein (around aa 1-134) (exact sequence is proprietary)

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/mL),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: K562, HeLa, MCF-7 cells. Colon or breast Carcinoma.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    RAD51 (DNA Repair Protein Homolog 1 (RAD51))

    Andere Bezeichnung

    RAD51

    Hintergrund

    RCA1/BRCA2 containing complex, subunit 5, BRCC5, DNA repair protein RAD51, FANCR, HsT16930, MRMV2, RAD51, RAD51 recombinase, RAD51A, RECA, RecA like protein, Recombination protein A,RAD51 (Prognostic and Response to Chemotherapy Marker)
    Cellular localisation: Nuclear

    Molekulargewicht

    37kDa

    Gen-ID

    5888, 631709

    UniProt

    Q06609

    Pathways

    DNA Reparatur
Sie sind hier:
Chat with us!